BioAge Labs, Inc

BIOANASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

45.8M

on 2026-06-30, from 34.2M on 2024-09-30 10-Q ↗

a raise that quarter, at its price

Newest

No limit

S-3ASR of 2026-03-24. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

3 of its filings are not read yet.

Warrants

32K

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

14.6 quarters

$318.7M on 2026-06-30 ÷ $21.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-01-21	Public offering	5,897,435	$19.50	$115.0M	424B5 ↗